Aspen Aerogels, Inc.
ASPN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.14 | 0.00 | -0.12 |
| FCF Yield | 1.03% | -3.46% | -1.40% | 2.18% |
| EV / EBITDA | 20.93 | 766.99 | -1.76 | 46.55 |
| Quality | ||||
| ROIC | -0.00% | -1.16% | -60.60% | 1.84% |
| Gross Margin | 28.49% | 32.45% | 28.98% | 38.29% |
| Cash Conversion Ratio | -2.37 | 0.43 | -0.02 | 3.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.12% | 27.85% | 32.57% | 35.90% |
| Free Cash Flow Growth | 135.28% | -128.28% | -135.19% | 41,966.00% |
| Safety | ||||
| Net Debt / EBITDA | 21.10 | 8.02 | 0.04 | -1.17 |
| Interest Coverage | 0.00 | -1.67 | -152.57 | 4.17 |
| Efficiency | ||||
| Inventory Turnover | 1.21 | 1.01 | 0.99 | 1.60 |
| Cash Conversion Cycle | 126.49 | 130.74 | 115.49 | 83.55 |